Evan Levy, MD
Gynecologic Oncology · West Palm Beach, FLNPI 1821529181
Payments from drug & device makers
Across 99 payments — averaging $35.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$534
- GSK$325
- AbbVie$262
- Johnson & Johnson$236
- LSI Solutions Inc$200
- Pfizer$181
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 4 | $534 |
| GSK | 6 | $325 |
| AbbVie | 7 | $262 |
| Johnson & Johnson | 11 | $236 |
| LSI Solutions Inc | 2 | $200 |
| Pfizer | 7 | $181 |
| Intuitive Surgical | 4 | $171 |
| Davol Inc. | 1 | $148 |
| Bayer | 9 | $148 |
| AstraZeneca(2 entities) | 6 | $115 |
| Merck | 4 | $100 |
| Genentech USA, Inc. | 3 | $90 |
| Tempus AI, Inc | 1 | $88 |
| Novartis | 3 | $84 |
| Radiometer America, Inc | 1 | $81 |
| Eisai Inc. | 3 | $78 |
| Tersera Therapeutics LLC | 2 | $61 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Incyte Corporation | 2 | $50 |
| Boehringer Ingelheim | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Sanofi | 2 | $43 |
| EMD Serono, Inc. | 1 | $38 |
| Springworks Therapeutics, Inc. | 1 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Geron Corporation | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Delcath Systems | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Adaptive Biotechnologies Corporation | 1 | $19 |
| Taiho Oncology, Inc. | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,479 in reported general payments places this provider in the 40th percentile of 117 gynecologic oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in West Palm Beach
- Bradley MonkWest Palm Beach$10.5M
- Howard GoodmanWest Palm Beach$43K
- Christopher McCannWest Palm Beach$32K
- Matthew SchlumbrechtMiami$16.7M
- Brian SlomovitzFort Lauderdale$13.9M
- John DiazMiami$3.7M
- Robert HollowayOrlando$3.1M
- Robert WenhamTampa$2.9M
- Hye Sook ChonTampa$2.4M
- Beverly LongSarasota$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.